Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Serin

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Bulletin Du Cancer|March 1, 1995
[Radiotherapy and concomitant cisplatin in stage III non-small cell bronchial cancer: results of a pilot study]F Reboul, P Vincent, B Chauvet, et al.
Bulletin Du Cancer|January 1, 1992
[Current role of chemotherapy in the treatment of invasive cancers of the bladder]B Chauvet, J L Davin, P Vincent, et al.
Human Mutation|February 17, 2001
Three novel BRCA1 germline mutations (1104delAA, 1276delTT, 3747delGA) detected in breast/ovarian cancer families identified in the south of FranceR Sauvan, T Noguchi, N Moyal-Amsellem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
'Parcours de Femme 2001': a French opinion survey on overall disease and everyday life management in 1870 women presenting with gynecological or breast cancer and their caregiversD Serin, J M Dilhuydy, P Romestaing, et al.
Bulletin Du Cancer|March 1, 1997
[Adjuvant combined radiochemotherapy: a feasibility study of a new strategy in stages I and II]D Serin, L Aimard, S Kirscher, et al.
Oncology|April 22, 2008
Phase II trial of pegylated liposomal doxorubicin-cyclophosphamide combination as first-line chemotherapy in older metastatic breast cancer patientsJ E Kurtz, F Rousseau, N Meyer, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 8, 2003
Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)I Fogelman, G M Blake, R Blamey, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 19, 2002
[Are there physical, technical and morphological limits to conformational radiotherapy?]R Garcia, R Oozeer, H Le Thanh, et al.
British Journal of Cancer|June 2, 2005
Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II studyD Serin, M Verrill, A Jones, et al.
Seminars in Oncology|August 1, 1995
Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancerV Dieras, M Marty, N Tubiana, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Bulletin Du Cancer|March 1, 1995
[Radiotherapy and concomitant cisplatin in stage III non-small cell bronchial cancer: results of a pilot study]F Reboul, P Vincent, B Chauvet, et al.
Bulletin Du Cancer|January 1, 1992
[Current role of chemotherapy in the treatment of invasive cancers of the bladder]B Chauvet, J L Davin, P Vincent, et al.
Human Mutation|February 17, 2001
Three novel BRCA1 germline mutations (1104delAA, 1276delTT, 3747delGA) detected in breast/ovarian cancer families identified in the south of FranceR Sauvan, T Noguchi, N Moyal-Amsellem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
'Parcours de Femme 2001': a French opinion survey on overall disease and everyday life management in 1870 women presenting with gynecological or breast cancer and their caregiversD Serin, J M Dilhuydy, P Romestaing, et al.
Bulletin Du Cancer|March 1, 1997
[Adjuvant combined radiochemotherapy: a feasibility study of a new strategy in stages I and II]D Serin, L Aimard, S Kirscher, et al.
Oncology|April 22, 2008
Phase II trial of pegylated liposomal doxorubicin-cyclophosphamide combination as first-line chemotherapy in older metastatic breast cancer patientsJ E Kurtz, F Rousseau, N Meyer, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 8, 2003
Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)I Fogelman, G M Blake, R Blamey, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 19, 2002
[Are there physical, technical and morphological limits to conformational radiotherapy?]R Garcia, R Oozeer, H Le Thanh, et al.
British Journal of Cancer|June 2, 2005
Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II studyD Serin, M Verrill, A Jones, et al.
Seminars in Oncology|August 1, 1995
Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancerV Dieras, M Marty, N Tubiana, et al.
Pageof 7